Neurocrine Biosciences
NBIX
#1415
Rank
โ‚น1.074 T
Marketcap
โ‚น10,610
Share price
1.42%
Change (1 day)
18.85%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น103.61 Billion

According to Neurocrine Biosciences 's latest financial reports the company has โ‚น103.61 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น85.87 B4.9%
2022-12-31โ‚น81.86 B54.63%
2021-12-31โ‚น52.94 B-9.62%
2020-12-31โ‚น58.58 B22.52%
2019-12-31โ‚น47.81 B5.05%
2018-12-31โ‚น45.51 B38.16%
2017-12-31โ‚น32.94 B57.73%
2016-12-31โ‚น20.88 B-17.12%
2015-12-31โ‚น25.19 B105.15%
2014-12-31โ‚น12.28 B36.42%
2013-12-31โ‚น9.00 B-4.95%
2012-12-31โ‚น9.47 B38.71%
2011-12-31โ‚น6.82 B20.14%
2010-12-31โ‚น5.68 B129.16%
2009-12-31โ‚น2.48 B-35.86%
2008-12-31โ‚น3.86 B-45.06%
2007-12-31โ‚น7.03 B-12.95%
2006-12-31โ‚น8.08 B-34.18%
2005-12-31โ‚น12.28 B-5.78%
2004-12-31โ‚น13.04 B-36.79%
2003-12-31โ‚น20.63 B75.82%
2002-12-31โ‚น11.73 B-23.99%
2001-12-31โ‚น15.43 B100.89%
2000-12-31โ‚น7.68 B94.06%
1999-12-31โ‚น3.96 B696.08%
1998-12-31โ‚น0.49 B-19.88%
1997-12-31โ‚น0.62 B52.85%
1996-12-31โ‚น0.40 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น68.27 B-34.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น215.44 B 107.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น0.80 B-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น296.88 B 186.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.110 T 971.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น599.18 B 478.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น20.84 B-79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น86.06 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA